C85.16
Unspecified B-cell lymphoma, intrapelvic lymph nodes
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified B-cell lymphoma affecting intrapelvic lymph nodes is a type of cancer that originates in the B-lymphocytes, a kind of white blood cell involved in the immune response. This condition involves abnormal growth of these cells within the lymph nodes located in the pelvic region. As a form of non-Hodgkin lymphoma, it can develop quietly over time and may exhibit various symptoms depending on its progression. Proper diagnosis and treatment are crucial for managing this disease effectively.
Causes & Symptoms
Clinical Causes: Genetic alterations or mutations in B-lymphocytes Immune system deficiencies or dysfunctions Certain infections, such as Epstein-Barr virus or Helicobacter pylori Environmental exposures to chemicals or radiation Age-related changes, as risk increases with age
Key Symptoms: Swelling or painless enlargement of pelvic lymph nodes B symptoms such as fever, night sweats, and unexplained weight loss Lower back or pelvic pain Fatigue and general malaise Potential abdominal fullness or discomfort due to enlarged lymph nodes
Diagnostic & Treatment
Diagnosis Path: Diagnosing unspecified B-cell lymphoma in the intrapelvic area involves several steps, including medical history assessment, physical examinations, blood tests, imaging studies, and tissue biopsy. Imaging techniques like CT scans, MRI, or PET scans help visualize lymph node enlargement and disease spread. The definitive diagnosis relies on examining a tissue sample under a microscope to identify characteristic cancer cell features and immunophenotyping results that confirm B-cell origin.
Treatment Protocols: Treatment options focus on controlling or eliminating the lymphoma and may include chemotherapy, targeted therapy, immunotherapy, radiation therapy, or a combination of these approaches. The specific treatment plan depends on the disease stage, patient health, and other individual factors. Participation in clinical trials may also be considered for access to emerging therapies, and supportive care is available to manage symptoms and treatment side effects.
Clinical Advice & FAQs
Billing Guidance
Is C85.16 a billable ICD-10 code?
Yes, C85.16 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.16?
Clinical documentation must specify the nature of Unspecified B-cell lymphoma, intrapelvic lymph nodes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference